MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11060-026-05573-9

Медицинская библиотека · Journal of neuro-oncology · 2026

Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy.

Ghoche Maged T, Gecici Neslihan Nisa, Miki Kenji, Yuan Fanen, Mantica Megan, Zinn Pascal O, Abdullah Kalil G

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Stereotactic brain biopsy (SBB) is a fundamental diagnostic procedure for intracranial lesions that are radiographically indeterminate or surgically inaccessible. While advances in navigation and perioperative care have enhanced safety, high-granularity data identifying independent predictors of diagnostic failure and complications in large longitudinal cohorts remain limited.

METHODS

We retrospectively reviewed 725 adult patients (≥18 years) who underwent SBB at a tertiary academic center between 2014 and 2025. Primary outcomes included diagnostic yield and procedure-related complications, specifically postoperative hemorrhage. A 1:4 nearest-neighbor matched case-control design was used to assess predictors of non-diagnostic yield (n = 184) and postoperative hemorrhage (n = 95), controlling for age and temporal technological changes. Multivariate logistic regression was utilized to calculate odds ratios (OR) and 95% confidence intervals (CI).

RESULTS

The overall diagnostic yield was 95.0% and the overall complication rate was 4.69%. Multivariate analysis revealed that low-yield pathology (e.g., low-grade glioma, inflammatory, or infectious lesions) was the sole independent predictor of a non-diagnostic result (OR 4.22, 95% CI 1.77–10.06, p = 0.001). Regarding surgical safety, deep-seated location was the only independent predictor of postoperative hemorrhage (OR 3.93, 95% CI 1.24–12.46, p = 0.019). Notably, no statistical differences in yield or safety were observed between robotic, frameless, and frame-based navigation platforms (p > 0.80). Median LOS was 1 day (mean 3.92 ± 5.23 days) and significantly declined over the study period (p = 0.023). Comparative analysis showed that LOS was identical between diagnostic and non-diagnostic groups.

CONCLUSIONS

Over a decade of institutional experience, SBB demonstrated high diagnostic accuracy and safety across all navigation platforms. These findings identify lesion biology as the primary driver of non-diagnostic sampling and deep-seated location as the chief risk factor for hemorrhage. The comparable hospital resource utilization regardless of diagnostic outcome, combined with a declining LOS, supports the feasibility of standardized early-discharge pathways in modern neuro-oncology. CLINICAL TRIAL NUMBER: Not applicable.

Для цитирования: Ghoche Maged T, Gecici Neslihan Nisa, Miki Kenji, Yuan Fanen, Mantica Megan, Zinn Pascal O, Abdullah Kalil G. Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy.. Journal of neuro-oncology. 2026. DOI: 10.1007/s11060-026-05573-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.